Kurs & Likviditet
Kalender
2025-02-12 | Bokslutskommuniké 2024 |
2024-11-13 | Kvartalsrapport 2024-Q3 |
2024-08-29 | Kvartalsrapport 2024-Q2 |
2024-05-30 | Ordinarie utdelning REDW 0.00 SEK |
2024-05-29 | Årsstämma 2024 |
2024-05-08 | Kvartalsrapport 2024-Q1 |
2024-04-24 | Extra Bolagsstämma 2024 |
2024-02-15 | Bokslutskommuniké 2023 |
2024-02-08 | Split REDW 100:1 |
2024-01-19 | Extra Bolagsstämma 2023 |
2023-11-23 | Kvartalsrapport 2023-Q3 |
2023-08-31 | Kvartalsrapport 2023-Q2 |
2023-06-28 | Årsstämma 2023 |
2023-05-10 | Ordinarie utdelning REDW 0.00 SEK |
2023-05-09 | Kvartalsrapport 2023-Q1 |
2023-02-15 | Bokslutskommuniké 2022 |
2022-10-31 | Kvartalsrapport 2022-Q3 |
2022-10-25 | Extra Bolagsstämma 2022 |
2022-08-31 | Kvartalsrapport 2022-Q2 |
2022-05-11 | Ordinarie utdelning REDW 0.00 SEK |
2022-05-10 | Kvartalsrapport 2022-Q1 |
2022-05-10 | Årsstämma 2022 |
2022-02-16 | Bokslutskommuniké 2021 |
2021-11-16 | Kvartalsrapport 2021-Q3 |
2021-08-27 | Kvartalsrapport 2021-Q2 |
2021-05-12 | Ordinarie utdelning REDW 0.00 SEK |
2021-05-11 | Årsstämma 2021 |
2021-05-11 | Kvartalsrapport 2021-Q1 |
2021-02-17 | Bokslutskommuniké 2020 |
2020-11-17 | Kvartalsrapport 2020-Q3 |
2020-08-28 | Kvartalsrapport 2020-Q2 |
2020-05-12 | Ordinarie utdelning REDW 0.00 SEK |
2020-05-11 | Kvartalsrapport 2020-Q1 |
2020-05-11 | Årsstämma 2020 |
2020-02-14 | Bokslutskommuniké 2019 |
2019-11-19 | Kvartalsrapport 2019-Q3 |
2019-08-30 | Kvartalsrapport 2019-Q2 |
2019-05-08 | Ordinarie utdelning REDW 0.00 SEK |
2019-05-07 | Kvartalsrapport 2019-Q1 |
2019-05-07 | Årsstämma 2019 |
2019-02-13 | Bokslutskommuniké 2018 |
2018-11-13 | Kvartalsrapport 2018-Q3 |
2018-08-29 | Kvartalsrapport 2018-Q2 |
2018-05-30 | Kvartalsrapport 2018-Q1 |
2018-05-30 | Årsstämma 2018 |
2018-04-26 | Ordinarie utdelning REDW 0.00 SEK |
2018-02-13 | Bokslutskommuniké 2017 |
2017-11-16 | Kvartalsrapport 2017-Q3 |
2017-08-30 | Kvartalsrapport 2017-Q2 |
2017-05-16 | Ordinarie utdelning REDW 0.00 SEK |
2017-05-15 | Årsstämma 2017 |
2017-05-15 | Kvartalsrapport 2017-Q1 |
2017-02-15 | Bokslutskommuniké 2016 |
2016-11-24 | Kvartalsrapport 2016-Q3 |
2016-08-30 | Kvartalsrapport 2016-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
In connection with convertible bond issues during the period July 2018 - January 2019, Redwood Pharma issued 287,958 warrants expiring on various occasions during 2021 and the beginning of 2022. After recalculation due to the rights issue in September 2019, the warrants entitle the holder to subscribe for a total of 293,716 shares.
The holder of the warrants has today used all of these to subscribe for new shares. Redwood Pharma will thus receive approximately SEK 2.1 million.
The subscription increases the number of shares in Redwood Pharma by 293,716 from 14,698,693 to 14,992,409. The share capital increases by SEK 58,743.20 from SEK 2,939,738.60 to SEK 2,998,481.80.
Martin Vidaeus, CEO Redwood Pharma AB (publ.)
Tel: +46 (0) 70 232 29 29
This information is information that Redwood Pharma AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on May 18, 2020.